Suppression of Triple-Negative Breast Cancer Aggressiveness by LGALS3BP via Inhibition of the TNF-α–TAK1–MMP9 Axis

The authors investigated the function and underlying mechanism of action of lectin galactoside-binding soluble 3 binding protein (LGALS3BP) in TNBC progression and determined the therapeutic potential of nanoparticle-mediated delivery of LGALS3BP in TNBC.